|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
5